注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
北京北陸藥業股份有限公司是一家主要從事對比劑產品、精神類藥品和降醣類藥品的研發、生產與銷售的中國公司。該公司的主要產品包括钆噴酸葡胺注射液、碘海醇注射液、碘帕醇注射液、碘克沙醇注射液、枸櫞酸鐵胺泡騰顆粒、瑞格列奈片、格列美脲片和九味鎮心顆粒等。該公司的產品主要在中國國內市場銷售。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Ying Yang | 44 | 2015 | Chairman of Supervisory Board |
Ying Dian Wang | 61 | 2019 | Independent Director |
Qing Xiang | 51 | 2007 | Non-Independent Director |
Ni Zeng | 30 | 2019 | Deputy GM, Financial Director & Non-Independent Director |
Bin Zheng | - | 2022 | Independent Director |
Gang Cao | - | 2022 | Independent Director |
Xu Wang | 38 | 2015 | Chairman & GM |
Gen Chang Zheng | 55 | 2008 | Chief Engineer & Employee Representative Member of Supervisory Board |
Li Zong | 53 | 2019 | Deputy GM & Director |
Zehui Shao | 44 | 2018 | Deputy GM, Secretary of the Board of Directors & Non-Independent Director |
Chengjie Hong | 42 | 2021 | Director of R&D Center & Non-Independent Director |
Wei Jiang | 51 | 2022 | Non-Employee Supervisor |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核